Clinical Trials Open to People Under 18
(91 trials open to new patients)

• Abortion (1 open to new patients)
• Acute Lymphoblastic Leukemia (2 open to new patients)
• Acute Myeloid Leukemia (2 open to new patients)
• Allogeneic Hematopoietic Cell Transplantation (1 open to new patients)
• Anemia (2 open to new patients)
• Ankylosing Spondylitis (1 open to new patients)
• Anorexia (1 open to new patients)
• Antiretroviral Toxicity (1 open to new patients)
• Arthritis (3 open to new patients)
• Asthma (1 open to new patients)
• Astrocytoma (1 open to new patients)
• Atopic Dermatitis (Eczema) (2 open to new patients)
• Autoimmune Disease (1 open to new patients)
• Brain Tumor (1 open to new patients)
• BRCA 1 Gene Mutation (1 open to new patients)
• BRCA 2 Gene Mutation (1 open to new patients)
• Breastfed Infants of Mothers on Select DOI (1 open to new patients)
• Cancer, General (1 open to new patients)
• CDKL5 Disorder (1 open to new patients)
• Cerebrotendinous Xanthomatosis (CTX) (1 open to new patients)
• Chronic Thromboembolic Pulmonary Hypertension (1 open to new patients)
• Colon Cancer (1 open to new patients)
• Colorectal Cancer (1 open to new patients)
• Congenital Heart Disease (1 open to new patients)
• Creatine Deficiency, X-linked (1 open to new patients)
• Crohn's Disease (4 open to new patients)
• Cyanosis (1 open to new patients)
• Cyanotic Congenital Heart Disease (1 open to new patients)
• Cystic Fibrosis (2 open to new patients)
• Cystinosis (1 open to new patients)
• Danon Disease (2 open to new patients)
• Deep Vein Thrombosis (1 open to new patients)
• Deletion and Duplication of Mitochondrial DNA (1 open to new patients)
• Disorders of the Immune System (1 open to new patients)
• Duchenne Muscular Dystrophy (1 open to new patients)
• Eating Disorder (1 open to new patients)
• Eosinophilic Colitis (1 open to new patients)
• Eosinophilic Esophagitis (2 open to new patients)
• Eosinophilic Gastritis (1 open to new patients)
• Eosinophilic Gastrointestinal Disorders (EGIDs) (1 open to new patients)
• Epstein Barr Virus (2 open to new patients)
• Facial Angiofibroma (1 open to new patients)
• Feeding Behavior (1 open to new patients)
• Feeding Disorder of Infancy or Early Childhood (1 open to new patients)
• Fibrosing Colonopathy (1 open to new patients)
• Fibrosis (2 open to new patients)
• FOXG1 Syndrome (1 open to new patients)
• Heart Transplant (1 open to new patients)
• Hematologic Malignancies (1 open to new patients)
• Hematological Malignancies (1 open to new patients)
• Hematopoietic Cell Transplantation (1 open to new patients)
• Hemophilia (2 open to new patients)
• Hernia (1 open to new patients)
• High Blood Pressure (1 open to new patients)
• Histiocytic Disorders (1 open to new patients)
• HIV/AIDS (6 open to new patients)
• Hodgkin's Lymphoma (1 open to new patients)
• Huntington's Disease (1 open to new patients)
• IDH1 Gene Mutation (1 open to new patients)
• IDH2 Gene Mutation (1 open to new patients)
• Immunotherapy (1 open to new patients)
• Inflammatory Bowel Disease (11 open to new patients)
• Infusion Reactions (1 open to new patients)
• Inherited Abnormalities of Platelets (1 open to new patients)
• Inherited Disorders of Metabolism (1 open to new patients)
• Inherited Eye Disease (1 open to new patients)
• Kawasaki Disease (1 open to new patients)
• Lactating Women on Select DOI (1 open to new patients)
• Leukemia (2 open to new patients)
• Liver Disease (2 open to new patients)
• Loss of Heterozygosity (1 open to new patients)
• Lung Cancer (3 open to new patients)
• Lung Non-Small Cell Carcinoma (1 open to new patients)
• Lung Non-Small Cell Squamous Carcinoma (1 open to new patients)
• Lymphoma (2 open to new patients)
• Lymphoproliferative Disorders (2 open to new patients)
• MECP2 Duplication Syndrome (1 open to new patients)
• Melanoma (2 open to new patients)
• Mitochondrial Diseases (1 open to new patients)
• Mitochondrial Disorders (1 open to new patients)
• Mitochondrial Genetic Disorders (1 open to new patients)
• Mucocutaneous Lymph Node Syndrome (1 open to new patients)
• Multiple Myeloma (1 open to new patients)
• Myelodysplastic Syndrome (1 open to new patients)
• Neoplasms by Site (1 open to new patients)
• Nephrolithiasis (1 open to new patients)
• Neurodevelopmental Abnormality (1 open to new patients)
• NLRC4-MAS (1 open to new patients)
• Non Hodgkin Lymphoma (1 open to new patients)
• Non-Small Cell Lung Cancer (2 open to new patients)
• Obesity (4 open to new patients)
• Otomycosis (1 open to new patients)
• Pain (1 open to new patients)
• Peripheral Arterial Disease (1 open to new patients)
• Prader-Willi Syndrome (1 open to new patients)
• Pregnancy (2 open to new patients)
• Premature Birth of Newborn (2 open to new patients)
• Premature Infant (3 open to new patients)
• Psoriasis (2 open to new patients)
• Pulmonary Function (1 open to new patients)
• Renal Fanconi Syndrome (1 open to new patients)
• Respiratory Syncytial Virus Infections (1 open to new patients)
• Respiratory Syncytial Virus (RSV) (1 open to new patients)
• Retinopathy of Prematurity (1 open to new patients)
• Rett Syndrome (1 open to new patients)
• Rheumatoid Arthritis (1 open to new patients)
• Seizures (1 open to new patients)
• Sepsis (1 open to new patients)
• Skin Cancer/Melanoma (2 open to new patients)
• Solid Organ Transplant Complications (1 open to new patients)
• Solid Tumor (2 open to new patients)
• Spinal Cord Injury (1 open to new patients)
• Steatohepatitis (1 open to new patients)
• Stem Cell Transplant Complications (1 open to new patients)
• Sudden Cardiac Death (1 open to new patients)
• Thrombosis (1 open to new patients)
• Thyroid Cancer (1 open to new patients)
• Tuberculosis (1 open to new patients)
• Tuberous Sclerosis (1 open to new patients)
• Urinary Tract Infection (2 open to new patients)
• Urolithiasis (1 open to new patients)
• Venous Thrombosis (1 open to new patients)
• Weight Management (1 open to new patients)
• XIAP Deficiency (1 open to new patients)